TARGRETIN Side Effects

6967775-9 | Febrile Neutropenia, Haematocrit Decreased
on Aug 24, 2010 Male patient from , weighting 141.1 lb, was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, haematocrit decreased. Targretin dosage: . During the same period patient was treated with SARGRAMOSTIM (View Sargramostim Review and Sargramostim Label ).

6967770-X | Malignant Neoplasm Progression
Patient was taking Targretin (View Usage). Patient had the following side effects: malignant neoplasm progression on Sep 01, 2010 from FRANCE Additional patient health information: Female patient , weighting 224.9 lb, was diagnosed with dyslipidaemia and. Targretin dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ACTRAPID (20 - 24 Iu) (View Actrapid Review and Actrapid Label ), BISINOPRIL 20 (View Bisinopril 20 Review and Bisinopril 20 Label ), KARDEGIC 75 (1 Bag) (View Kardegic 75 Review and Kardegic 75 Label ), TAHOR 10 (1 Bag) (View Tahor 10 Review and Tahor 10 Label ). Patient was hospitalized.

6932889-6 | Hypoglycaemia
Adverse event was reported on Aug 12, 2010 by a Female patient taking Targretin (View Usage) (Dosage: ) . Location: AUSTRIA , 69 years of age, After Targretin was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), AEROMUC (View Aeromuc Review and Aeromuc Label ), BERODUALIN (View Berodualin Review and Berodualin Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), CRESTOR (View Crestor Review and Crestor Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

6927517-X | Malignant Neoplasm Progression
on Aug 06, 2010 Female patient from FRANCE , weighting 224.9 lb, was diagnosed with dyslipidaemia and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: malignant neoplasm progression. Targretin dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ACTRAPID (20 - 24 Iu) (View Actrapid Review and Actrapid Label ), BISINOPRIL 20 (View Bisinopril 20 Review and Bisinopril 20 Label ), KARDEGIC 75 (1 Bag) (View Kardegic 75 Review and Kardegic 75 Label ), TAHOR 10 (1 Bag) (View Tahor 10 Review and Tahor 10 Label ).


6918254-6 | Hypoglycaemia
on Jul 30, 2010 Female patient from AUSTRIA , 69 years of age, was treated with Targretin (View Usage). Patient had the following side effects: hypoglycaemia. Targretin dosage: . During the same period patient was treated with AEROMUC (View Aeromuc Review and Aeromuc Label ), BERODUALIN (View Berodualin Review and Berodualin Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), CRESTOR (View Crestor Review and Crestor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6894549-X | Progressive Multifocal Leukoencephalopathy
Patient was taking Targretin (View Usage). After Targretin was administered, patient had the following side effects: progressive multifocal leukoencephalopathy on Jul 20, 2010 from FRANCE Additional patient health information: Male patient , 48 years of age, . Targretin dosage: . Patient was hospitalized.

6678864-0 | Cardiac Arrest
Adverse event was reported on Apr 08, 2010 by a Male patient taking Targretin (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 86 years of age, weighting 313.1 lb, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6671323-0 | Inflammation, Pyrexia
on Mar 31, 2010 Male patient from FRANCE , 72 years of age, was diagnosed with hypothyroidism and was treated with Targretin (View Usage). Patient had the following side effects: inflammation, pyrexia. Targretin dosage: . During the same period patient was treated with METHOTREXATE BELLON (View Methotrexate Bellon Review and Methotrexate Bellon Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), NOVATREX (View Novatrex Review and Novatrex Label ). Patient was hospitalized.

6655079-3 | Disease Progression, Pancytopenia
on Mar 18, 2010 Male patient from UNITED STATES , weighting 178.6 lb, was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: disease progression, pancytopenia. Targretin dosage: . During the same period patient was treated with SARGRAMOSTIM (View Sargramostim Review and Sargramostim Label ). Patient was hospitalized.

6619560-5 | Cough, Decreased Appetite, Fatigue, Hypoxia, Lung Infiltration
Patient was taking Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: cough, decreased appetite, fatigue, hypoxia, lung infiltration on Feb 25, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 143.3 lb, . Targretin dosage: .

6546523-0 | Cataract
Adverse event was reported on Jan 14, 2010 by a Male patient taking Targretin (View Usage) (Dosage: 6-8 Capsules 75mg) was diagnosed with hypothyroidism and. Location: FRANCE , 66 years of age, Patient had the following side effects: cataract (What is cataract?). During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6538191-9 |
on Jan 08, 2010 Female patient from GERMANY , 82 years of age, was diagnosed with hypothyroidism and was treated with Targretin (View Usage). . Targretin dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6410427-4 | Pulmonary Fibrosis
on Oct 12, 2009 Male patient from GERMANY , 54 years of age, was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary fibrosis (What is pulmonary fibrosis?). Targretin dosage: .

6360751-9 | Neoplasm
Patient was taking Targretin (View Usage). Patient had the following side effects: neoplasm on Sep 08, 2009 from ISRAEL Additional patient health information: Male patient , 52 years of age, weighting 180.8 lb, was diagnosed with mycosis fungoides and. Targretin dosage: .

6333065-0 | Hypercholesterolaemia, Hypertriglyceridaemia, Hypothyroidism, Lymphoma
Adverse event was reported on Aug 18, 2009 by a Female patient taking Targretin (View Usage) (Dosage: ) . Location: FRANCE , 59 years of age, After Targretin was administered, patient had the following side effects: hypercholesterolaemia, hypertriglyceridaemia, hypothyroidism, lymphoma (What is lymphoma?).

6332604-3 | Disease Progression, Haemoptysis
on Aug 25, 2009 Male patient from UNITED STATES , weighting 196.2 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), reflux gastritis, headache (What is headache?) and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, haemoptysis. Targretin dosage: . During the same period patient was treated with FISH OIL CAPSULES (View Fish Oil Capsules Review and Fish Oil Capsules Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SYNTAX (1 Pill) (View Syntax Review and Syntax Label ), MULTI VITAMINS (1 Pill) (View Multi-vitamins Review and Multi-vitamins Label ), ADVIL (View Advil Review and Advil Label ). Patient was hospitalized.

6318097-0 | Delirium, Disease Progression, Haemoptysis, Malignant Neoplasm Progression, Metastases To Liver, Pain, Pulmonary Mass, Thyroid Cancer Metastatic
on Aug 18, 2009 Male patient from UNITED STATES , weighting 196.2 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), reflux gastritis, headache (What is headache?) and was treated with Targretin (View Usage). Patient had the following side effects: delirium, disease progression, haemoptysis, malignant neoplasm progression, metastases to liver, pain (What is pain?), pulmonary mass, thyroid cancer metastatic. Targretin dosage: . During the same period patient was treated with FISH OIL CAPSULES (View Fish Oil Capsules Review and Fish Oil Capsules Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SYNTAX (1 Pill) (View Syntax Review and Syntax Label ), MULTI VITAMINS (1 Pill) (View Multi-vitamins Review and Multi-vitamins Label ), ADVIL (View Advil Review and Advil Label ). Patient was hospitalized.

6309509-7 | Erythema, Skin Exfoliation
Patient was taking Targretin (View Usage). After Targretin was administered, patient had the following side effects: erythema, skin exfoliation on Aug 10, 2009 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with mycosis fungoides and. Targretin dosage: .

6307711-1 | Pyrexia, Swelling Face
Adverse event was reported on Jul 30, 2009 by a Male patient taking Targretin (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 72 years of age, weighting 198.2 lb, Patient experienced the following unwanted or unexpected effects: pyrexia, swelling face. During the same period patient was treated with SARGRAMOSTIM (View Sargramostim Review and Sargramostim Label ). Patient was hospitalized.

6299573-6 | Hodgkin's Disease
on Jul 27, 2009 Male patient from UNITED STATES , 51 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient had the following side effects: hodgkin's disease (What is hodgkin's disease?). Targretin dosage: .

6269132-X | Hypoacusis
on Jul 08, 2009 Male patient from FRANCE , 50 years of age, was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: hypoacusis. Targretin dosage: 6 Capsules.

6258110-2 | Disease Progression, Haemoptysis
Patient was taking Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, haemoptysis on Jun 24, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 196.2 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), reflux gastritis, headache (What is headache?) and. Targretin dosage: . During the same period patient was treated with FISH OIL CAPSULES (View Fish Oil Capsules Review and Fish Oil Capsules Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SYNTAX (1 Pill) (View Syntax Review and Syntax Label ), MULTI VITAMINS (1 Pill) (View Multi-vitamins Review and Multi-vitamins Label ), ADVIL (View Advil Review and Advil Label ). Patient was hospitalized.

6244727-8 | Pulmonary Fibrosis
Adverse event was reported on Jun 16, 2009 by a Male patient taking Targretin (View Usage) (Dosage: ) . Location: GERMANY , 54 years of age, Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?).

6235874-5 | Disease Progression
on Jun 08, 2009 Male patient from UNITED STATES , weighting 196.2 lb, was diagnosed with thyroid cancer (What is thyroid cancer?), reflux gastritis, headache (What is headache?) and was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: disease progression. Targretin dosage: . During the same period patient was treated with FISH OIL CAPSULES (View Fish Oil Capsules Review and Fish Oil Capsules Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SYNTAX (1 Pill) (View Syntax Review and Syntax Label ), MULTI VITAMINS (1 Pill) (View Multi-vitamins Review and Multi-vitamins Label ), ADVIL (View Advil Review and Advil Label ). Patient was hospitalized.

6207718-9 | Hodgkin's Disease, Respiratory Tract Infection
on May 11, 2009 Female patient from GERMANY , 64 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: hodgkin's disease (What is hodgkin's disease?), respiratory tract infection. Targretin dosage: Oral. During the same period patient was treated with PSORALEN UVA (PSORALENS FOR TOPICAL USE) (View Psoralen-uva (psoralens For Topical Use) Review and Psoralen-uva (psoralens For Topical Use) Label ).

6155439-3 | Dehydration, Hypercalcaemia, Sepsis
Patient was taking Targretin (View Usage). Patient had the following side effects: dehydration, hypercalcaemia, sepsis (What is sepsis?) on Apr 07, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, was diagnosed with adult t-cell lymphoma/leukaemia and. Targretin dosage: . During the same period patient was treated with INTERFERON (1.5 Million Units) (View Interferon Review and Interferon Label ).

6149914-5 | Choroiditis, Depressed Mood, Dysuria, Fatigue, Headache, Hyperhidrosis, Insomnia, International Normalised Ratio, Visual Impairment
Adverse event was reported on Apr 02, 2009 by a Male patient taking Targretin (View Usage) (Dosage: ) was diagnosed with mycosis fungoides, blood cholesterol increased, arrhythmia (What is arrhythmia?) and. Location: GERMANY , weighting 202.8 lb, After Targretin was administered, patient had the following side effects: choroiditis, depressed mood, dysuria, fatigue, headache (What is headache?), hyperhidrosis, insomnia, international normalised ratio, visual impairment. During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LANITOP (View Lanitop Review and Lanitop Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6085803-2 | Convulsion
on Feb 11, 2009 Male patient from ITALY , 66 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Targretin dosage: . During the same period patient was treated with DELTACORTENE (View Deltacortene Review and Deltacortene Label ).

6059556-8 | Hypertriglyceridaemia, Hypothyroidism, Neuropathy Peripheral, Therapeutic Response Unexpected
on Jan 19, 2009 Male patient from FRANCE , weighting 169.8 lb, was diagnosed with mycosis fungoides, hypertension, pruritus, hypertriglyceridaemia, hypothyroidism and was treated with Targretin (View Usage). Patient had the following side effects: hypertriglyceridaemia, hypothyroidism, neuropathy peripheral, therapeutic response unexpected. Targretin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), ATARAX (View Atarax Review and Atarax Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), TAHOR (View Tahor Review and Tahor Label ).

6048930-1 | Choroiditis, Depressed Mood, Dysuria, Fatigue, Headache, Hyperhidrosis, Insomnia, International Normalised Ratio, Visual Impairment
Patient was taking Targretin (View Usage). After Targretin was administered, patient had the following side effects: choroiditis, depressed mood, dysuria, fatigue, headache (What is headache?), hyperhidrosis, insomnia, international normalised ratio, visual impairment on Jan 13, 2009 from GERMANY Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with mycosis fungoides, blood cholesterol increased, arrhythmia (What is arrhythmia?) and. Targretin dosage: . During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LANITOP (View Lanitop Review and Lanitop Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6016764-X | Choroiditis, Depressed Mood, Dysuria, Fatigue, Headache, Hyperhidrosis, Insomnia, International Normalised Ratio, Visual Impairment
Adverse event was reported on Dec 09, 2008 by a Male patient taking Targretin (View Usage) (Dosage: ) was diagnosed with mycosis fungoides, blood cholesterol increased, arrhythmia (What is arrhythmia?) and. Location: GERMANY , weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: choroiditis, depressed mood, dysuria, fatigue, headache (What is headache?), hyperhidrosis, insomnia, international normalised ratio, visual impairment. During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LANITOP (View Lanitop Review and Lanitop Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6000919-4 | Cerebrovascular Accident
on Dec 02, 2008 Male patient from UNITED STATES , 79 years of age, weighting 240.3 lb, was diagnosed with t-cell lymphoma and was treated with Targretin (View Usage). Patient had the following side effects: cerebrovascular accident. Targretin dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), TRICOR (View Tricor Review and Tricor Label ). Patient was hospitalized.

5968155-5 | Alveolitis Allergic, Hepatitis
on Nov 14, 2008 Male patient from UNITED STATES , 32 years of age, weighting 231.5 lb, was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: alveolitis allergic, hepatitis (What is hepatitis?). Targretin dosage: . Patient was hospitalized.

5811477-9 | Lymphoma
Patient was taking Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?) on Mar 28, 2008 from UNITED STATES Additional patient health information: Male patient , 74 years of age, was diagnosed with mycosis fungoides and. Targretin dosage: .

5806743-7 | Asthenia, Confusional State, Headache, Infection, Lobar Pneumonia, Nausea, Neck Pain, Oropharyngeal Pain, Oxygen Saturation Decreased
Adverse event was reported on Jul 09, 2008 by a Female patient taking Targretin (View Usage) (Dosage: 525mg Once Daily Oral) was diagnosed with non-small cell lung cancer stage iv and. Location: UNITED STATES , weighting 130.0 lb, Patient had the following side effects: asthenia, confusional state, headache (What is headache?), infection (What is infection?), lobar pneumonia, nausea (What is nausea?), neck pain, oropharyngeal pain, oxygen saturation decreased. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), PARAPLATIN (View Paraplatin Review and Paraplatin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5800631-8 | Asthenia, Confusional State, Headache, Nausea, Neck Pain, Oropharyngeal Pain, Oxygen Saturation Decreased, Pneumonia, Pollakiuria
on Jul 02, 2008 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: asthenia, confusional state, headache (What is headache?), nausea (What is nausea?), neck pain, oropharyngeal pain, oxygen saturation decreased, pneumonia (What is pneumonia?), pollakiuria. Targretin dosage: 525mg Once Daily Oral. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5781225-X | Blood Triglycerides Increased, Cerebrovascular Accident
on Jun 03, 2008 Male patient from UNITED STATES , 78 years of age, was diagnosed with t-cell lymphoma and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: blood triglycerides increased, cerebrovascular accident. Targretin dosage: 375 Mg, 5 In 1 D, Oral, 675 Mg, 9 In 1 D, Oral, 450 Mg, 6 In 1 D, Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), TRICOR (View Tricor Review and Tricor Label ).

5765392-X | Acute Febrile Neutrophilic Dermatosis, Anaemia, Blood Lactate Dehydrogenase Increased, Chills, Eosinophil Count Decreased, Fatigue, Granuloma, Lymphocyte Count Decreased, Pyrexia
Patient was taking Targretin (View Usage). Patient had the following side effects: acute febrile neutrophilic dermatosis, anaemia, blood lactate dehydrogenase increased, chills, eosinophil count decreased, fatigue, granuloma, lymphocyte count decreased, pyrexia on May 21, 2008 from GERMANY Additional patient health information: Male patient , 50 years of age, was diagnosed with lymphoma (What is lymphoma?), prophylaxis and. Targretin dosage: 525 Mg, Oral. During the same period patient was treated with FENOFIBRATE (250 Mg,) (View Fenofibrate Review and Fenofibrate Label ), VORINOSTAT (200 Mg,) (View Vorinostat Review and Vorinostat Label ). Patient was hospitalized.

5756371-7 | Cerebrovascular Accident, Dyspnoea, Transient Ischaemic Attack
Adverse event was reported on May 16, 2008 by a Male patient taking Targretin (View Usage) (Dosage: 525 Mg, Oral) was diagnosed with t-cell lymphoma and. Location: UNITED STATES , 78 years of age, weighting 229.3 lb, After Targretin was administered, patient had the following side effects: cerebrovascular accident, dyspnoea, transient ischaemic attack. During the same period patient was treated with ACCUPRIL (View Accupril Review and Accupril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), TRICOR (View Tricor Review and Tricor Label ), OMEGA 3 (FISH OIL) (View Omega 3 (fish Oil) Review and Omega 3 (fish Oil) Label ). Patient was hospitalized.

5706494-3 | Dermatitis Exfoliative, Lymphadenopathy, Pruritus, Sezary Cells Increased, Staphylococcal Sepsis
on Mar 28, 2008 Male patient from UNITED STATES , 63 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, lymphadenopathy, pruritus, sezary cells increased, staphylococcal sepsis. Targretin dosage: 650 Mg, Oral.

5705477-7 | Lymphoma, Pulmonary Mass
on Mar 28, 2008 Female patient from UNITED STATES , 69 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient had the following side effects: lymphoma (What is lymphoma?), pulmonary mass. Targretin dosage: 300 Mg, Oral.

5705476-5 | Confusional State, Lymphoma, Metastases To Meninges, Mycosis Fungoides, Pneumonia, Sepsis
Patient was taking Targretin (View Usage). After Targretin was administered, patient had the following side effects: confusional state, lymphoma (What is lymphoma?), metastases to meninges, mycosis fungoides, pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Mar 28, 2008 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with mycosis fungoides and. Targretin dosage: 450 Mg, Oral.

5705248-1 | Necrosis, Night Sweats, Pyrexia, Rash Papular, T-cell Lymphoma
Adverse event was reported on Mar 28, 2008 by a Male patient taking Targretin (View Usage) (Dosage: 600 Mg/d, Oral) was diagnosed with mycosis fungoides and. Location: UNITED STATES , 40 years of age, Patient experienced the following unwanted or unexpected effects: necrosis, night sweats, pyrexia, rash papular, t-cell lymphoma.

5705244-4 | Lymphadenopathy, Parotid Gland Enlargement
on Mar 28, 2008 Male patient from UNITED STATES , 59 years of age, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient had the following side effects: lymphadenopathy, parotid gland enlargement. Targretin dosage: 300 Mg, Oral.

5702816-8 | Chills, Nausea
on Apr 10, 2008 Male patient from UNITED STATES , 67 years of age, weighting 245.0 lb, was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: chills, nausea (What is nausea?). Targretin dosage: 675 Mg Once Daily Po. Patient was hospitalized.

5689665-4 | Disease Progression, Mycosis Fungoides
Patient was taking Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, mycosis fungoides on Feb 25, 2008 from SPAIN Additional patient health information: Female patient , 51 years of age, was diagnosed with mycosis fungoides and. Targretin dosage: 450 Mg, Oral. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), INTERFERON ALFA (INTERFERON ALFA) (View Interferon Alfa (interferon Alfa) Review and Interferon Alfa (interferon Alfa) Label ). Patient was hospitalized.

5682508-4 | Blood Triglycerides Increased, Condition Aggravated, High Density Lipoprotein Decreased, Sepsis
Adverse event was reported on Mar 26, 2008 by a Male patient taking Targretin (View Usage) (Dosage: 300mg Bid Po) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , weighting 211.6 lb, Patient had the following side effects: blood triglycerides increased, condition aggravated, high density lipoprotein decreased, sepsis (What is sepsis?).

5676707-5 | Disease Progression
on Feb 09, 2007 Male patient from UNITED STATES , 63 years of age, weighting 189.6 lb, was diagnosed with lymphoma (What is lymphoma?), mycosis fungoides and was treated with Targretin (View Usage). After Targretin was administered, patient had the following side effects: disease progression. Targretin dosage: 150 Mg, Qd, Oral.

5637805-5 | Asthenia, Oedema Peripheral, Pulmonary Oedema
on Feb 05, 2008 Female patient from UNITED STATES , 70 years of age, weighting 200.6 lb, was diagnosed with mycosis fungoides and was treated with Targretin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, oedema peripheral, pulmonary oedema. Targretin dosage: 300 Mg, 4 In 1 D, Oral. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), COZAAR (View Cozaar Review and Cozaar Label ), NAMENDA (View Namenda Review and Namenda Label ), LYRICA (View Lyrica Review and Lyrica Label ), LASIX (View Lasix Review and Lasix Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

5626940-3 | Circulatory Collapse, Exercise Tolerance Decreased, Nocturnal Dyspnoea, Orthopnoea, Pericardial Effusion, Pitting Oedema, Retinoic Acid Syndrome
Patient was taking Targretin (View Usage). Patient had the following side effects: circulatory collapse, exercise tolerance decreased, nocturnal dyspnoea, orthopnoea, pericardial effusion, pitting oedema, retinoic acid syndrome on Jan 30, 2008 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with acute myeloid leukaemia and. Targretin dosage: 150 Mg/m2,oral. Patient was hospitalized.